Kamyar Asadipooya, MD, Endocrinology Fellow

Kamyar Asadipooya, MDI obtained my MD in 1999 and Internal Medicine Board in 2007 from Shiraz University of Medical Sciences, Iran. In 2007, I became assistant professor of Internal Medicine in Bushehr University of Medical Science, Iran. I received the best “Research Student” award in 1999 and the best attending award in 2009.

I joined Kansas University Medical Center in 2012 and received two grants with endocrine department. I started clinical endocrinology fellowship in NYU, in 2015. I recently joined the Diabetes Research Program at NYU. My current research project is explanation of signaling pathway of RAGE-mDIA1 interaction.

Presentations
September 18, 2016; American Society of Bone and Mineral Research (ASBMR) Atlanta Georgia, GA, USA: Osteoporosis of Systemic Mastocytosis Might Have to be Treated Differently
September 14, 2014; American Society of Bone and Mineral Research (ASBMR) Houston, TX, USA: Transient osteoporosis of hip associated with alcohol consumption: A case report and review of literature.

Editorial Positions
Reviewer: Journal of Metabolism Clinical and Experimental  
Reviewer: American Journal of Cardiology  
Reviewer: Journal of Endocrinology and Metabolism
Reviewer: International Journal of Infectious Diseases

Publications

  1. Greene LW, Asadipooya K, Corradi PF, Akin C. Endocrine Manifestations of Systemic Mastocytosis in Bone. Rev Endocr Metab Disord. 2016 May 30.
  2. Asadipooya K, Graves L, Lukert BP, Kalantarhormozi MR, Assadi M, Ostovar A, Larijani B, Nabipour I. Osteocalcin is a Predictor for Diabetes Mellitus in Postmenopausal Women  and Correlated with Oral Intake of Vitamin K. Mediterranean Journal of Nutrition and Metabolism. 2015 Sep 8 (3): 231-241.
  3. Darabi H, Raeisi A, Kalantarhormozi MR, Ostovar A, Assadi M, Asadipooya K, Vahdat K, Dobaradaran S, Nabipour I. Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. Medicine (Baltimore). 2015 Aug; 94(33):e1347.
  4. Kalantarhormozi MR, Assadi M, Vahdat K, Asadipooya K, Ostovar A, Raissi K, Darabi H, Farrokhi S, Dobaradaran S, Farrokhnia M, Nabipour I. Chlamydia Pneumoniae and Helicobacter Pylori IgG Seropositivities Are not Predictors of Osteoporosis-Associated Bone Loss: a Prospective Cohort Study. J Bone Miner Metab. 2015 Jun 9.
  5. Vahdat K, Dadjou H, Hadavand F, Kalantarhormozi MR, Ostovar A, Assadi M, Asadipooya K, Farrokhi S, Darabi H, Dobaradaran S, Nabipour I. The Association of Chlamydia Pneumoniae IgG Seropositivity with an Atherogenic Lipid Profile in a General Population: The Persian Gulf Healthy Heart Study. Austin J Endocrinol Diabetes. 2014; 1 (6): 1026.
  6. Vahdat K, Ostovar A, Hadavand F, PourbehiMR, Assadi M, Kalantarhormozi MR, Asadipooya K, Haeri MJ, Farrokhi S, Dobaradaran S, Nabipour I. Serum Homocysteine Levels Are Associated with Infectious Burden: the Persian Gulf Healthy Heart Study. Exp Clin Cardiol. 2014; 20 (5): 3503-3526.
  7. Ravanbod MR, Asadipooya K, Kalantar-Hormozi MR, Nabipour I, Omrani GR. Treatment of Iron Deficiency Anemia in the Patients with Subclinical Hypothyroidism. American Journal of Medicine. 2013 May; 126(5): 420-424.
  8. Kalantar Hormozi MR, Nabipour I, Assadi M, Asadipooya K, Amini A, Omrani GR,  Subclinical hyperthyroidism. Iranian South Medical Journal. 2013; 16(3).
  9. Movahed A, Larijani B, Nabipour I, Kalantarhormozi M, Asadipooya K, Vahdat K, Akbarzadeh S, Farrokhnia M, Assadi M, Amirinejad R, Bargahi A, Sanjdideh Z. Reduced Serum Osteocalcin Concentrations Are Associated with Type 2 Diabetes Mellitus and the Metabolic Syndrome Components in Postmenopausal Women: the Crosstalk Between Bone and Energy Metabolism. J Bone Miner Metab. 2012 Nov; 36 (6):683-691.
  10. Asadipooya K, Kalantar-Hormozi M, Nabipour I. Pioglitazone Reduces Central Obesity in Polycystic Ovary Syndrome Women. Gynecolo Endocrinol. 2012 Jan; 28(1): 16-19.
  11. Asadipooya K, Dehghanian A, Omrani GH, Abbasi F. Short-Course Treatment in Neurobrucellosis: A study in Iran. Neurol India. 2011 Jan-Feb; 59(1): 101-103.
  12. Kalantarhormozi MR, Nabipour I, Assadi M, Asadipooya K, Zendehboudi S, Omrani GR. Subclinical Hypothyroid. Iranian South Medical of Journal. 2011; 14(1).
  13. Kalantarhormozi MR, Omrani GR, Asadipooya K, Monshi H, Sehat MR. Barr-Shaver-Carr Syndrome: a Case Report. Iranian South Medical of Journal. 2010; 13(1).
  14. Mowla A, Asadipooya K. Delusional Parasitosis Following Heroin Withdrawal: a Case Report. Am J Addict. 2009 Jul-Aug; 18 (4): 334-335.
  15. Asadi-Pooya AA, Asadipooya K. Antinuclear Antibodies in Children with Epilepsy Treated by Carbamazepine. Epilepsy Res. 2008 Aug; 80 (2-3): 229-230.
  16. Karimi M, Asadi-Pooya AA, Khademi B, Asadipooya K, Yarmohammadi H. Evaluation of the Incidence of Sensorineural Hearing Loss in Beta-thalassemia Major Patients under Regular Chelation Therapy with Desferrioxamine. Acta Haematol. 2002; 108(2):79-83.